Search

Memorial Sloan Kettering and Bright Horizons, the nation’s largest provider of employer-sponsored childcare, recently opened a new, state-of-the-art childcare facility for exclusive use of MSK employees.

… Monday, March 8, 2021 Memorial Sloan Kettering Cancer Center (MSK) and Bright Horizons, the nation’s largest provider of employer-sponsored childcare, recently opened a new, state-of-the-art childcare facility for exclusive use of MSK employees. Located only a few short blocks from MSK’s flagship location

The Gerstner Sloan Kettering Summer Undergraduate Research Program (SURP) will welcome 25 students to this year's ten-week program.

… Sunday, May 1, 2011 Designed to allow outstanding undergraduate students to obtain hands-on research experience in Memorial Sloan Kettering laboratories, the 2011 Summer Undergraduate Research Program will have a class of 13 women and 12 men — one freshman, seven sophomores, and 17 juniors — who are

Memorial Sloan Kettering Cancer Center (MSK) today announced a transformative gift from the Commonwealth Foundation for Cancer Research to benefit the Center for Experimental Therapeutics, a multidisciplinary research and drug development group at MSK. With this gift, the Commonwealth Foundation for Cancer Research continues their nearly three-decade commitment to the Center for Experimental Therapeutics, which was initially founded in 2002 with a generous gift from the Foundation.

… Wednesday, September 13, 2023 Memorial Sloan Kettering Cancer Center (MSK) today announced a transformative gift from the Commonwealth Foundation for Cancer Research to benefit the  Center for Experimental Therapeutics , a multidisciplinary research and drug development group at MSK. With this gift,

The May 6 session of “MSK Science Spotlight” features Ross Levine, MD, Laurence Joseph Dineen Chair in Leukemia Research and Chief, Molecular Cancer Medicine Service, Human Oncology and Pathogenesis Program, presenting his work on “Deciphering and Targeting Clonal Evolution.”

… Wednesday, May 6, 2020 The May 6 session of “ MSK Science Spotlight ” features Ross Levine, MD , Laurence Joseph Dineen Chair in Leukemia Research and Chief, Molecular Cancer Medicine Service, Human Oncology and Pathogenesis Program, presenting his work on “Deciphering and Targeting Clonal Evolution.

As we celebrate National Nurses Week, Memorial Sloan Kettering Cancer Center (MSK) and The Robbins Family Foundation recognize seven distinguished nursing staff members for their exemplary service. Each member of this select group is being honored with the inaugural 2020 Robbins Family Award for Nursing Excellence.

… Monday, May 11, 2020 Jessica Agostini Jessica Agostini Joseph Kesselbrenner Joseph Kesselbrenner Meghan Salcedo Meghan Salcedo Jennifer Fox Jennifer Fox Kristen Fessele Kristen Fessele Andrea Smith Andrea Smith Leon Chen Leon Chen As we celebrate National Nurses Week, Memorial Sloan Kettering Cancer

Read about some of the biggest scientific discoveries made by MSK researchers in 2022.

… Wednesday, December 14, 2022 Researchers at Memorial Sloan Kettering Cancer Center (MSK) continued to make meaningful strides against cancer in 2022. Laboratory studies conducted at the Sloan Kettering Institute (SKI) Sloan Kettering Institute (SKI) and across the institution contributed to the global

Learn about the evolution of the Integrative Medicine Service (IMS) at Memorial Sloan Kettering, which was founded in 1999.

… Tuesday, December 24, 2019 Two women doing yoga together Yoga therapist Tina Paul (back) and Lori Weisenberg-Catalano work on form. Chief of the Integrative Medicine Service Jun Mao Chief of the Integrative Medicine Service Jun Mao performs acupuncture on a patient. Man playing guitar while child watches

Dr. Maciejowski studies chromosome instability and its role in cancer. In a May 2021 interview, he discussed how he got into science and what his lab has been focusing on lately.

… Tuesday, May 18, 2021 Molecular biologist John Maciejowski joined the faculty of the Sloan Kettering Institute in 2017 after completing his doctorate at MSK’s Gerstner Sloan Kettering Graduate School of Biomedical Sciences and his postdoctoral training at The Rockefeller University. He was in GSK’s first

Investigators at Memorial Sloan Kettering have developed a new tool that could help them advance the understanding of human embryonic stem cells.

… Wednesday, October 1, 2008 Summary Investigators at Memorial Sloan Kettering have developed a new tool that could help them advance the understanding of human embryonic stem cells. Investigators at Memorial Sloan Kettering have developed a new tool that could help them advance the understanding of human

An experimental drug is showing promise for the treatment of men with an aggressive form of advanced prostate cancer. A new multicenter study has concluded that the targeted therapy MDV3100 is safe and effective for patients with castration-resistant prostate cancer, known for its poor prognosis and limited treatment options.

… Wednesday, April 14, 2010 An experimental drug is showing promise for the treatment of men with an aggressive form of advanced prostate cancer . A new multicenter study has concluded that the targeted therapy MDV3100 is safe and effective for patients with castration-resistant prostate cancer (CRPC),